Skip to content

Medtronic

US · MDT #176 by market cap Listed 1970
99.94 -0.67 -0.67%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 6 in the most recent period (2026/Q4).
  • Total institutional ownership rose 4.1 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
95.65% +4.07pp
Institutions
2,658 -6
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund76.67%
Public Company5.56%
Hedge Fund4.88%
Private Company3.80%
Government Pension Fund2.14%
Sovereign Wealth Fund1.45%
Insurance Company0.46%
Family Office/Trust0.31%
Government0.15%
Other4.59%

Top holders as of 2026-09-30

BlackRock 9.70% · 118.77M sh
Vanguard Capital Management, LLC 7.43% · 90.98M sh
State Street Global Advisors 5.39% · 65.99M sh
Vanguard Portfolio Management, LLC 2.80% · 34.30M sh
Geode Capital Management, LLC 2.52% · 30.88M sh
Other 73.99%
UBS Asset Management 2.01% · 24.66M sh
Capital Research 1.87% · 22.84M sh
J.P. Morgan Asset Management, Inc. 1.57% · 19.26M sh
MFS Investment Management 1.48% · 18.09M sh
Franklin Resources 1.48% · 18.08M sh
Deutsche Asset & Wealth Management 1.45% · 17.74M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 27 buys · 18 sells

NameRoleStake
Geoffrey Martha Chairperson & CEO 0.01%
Randall Hogan Independent Director 0.00%
Brett Wall Former Officer 0.00%
Craig Arnold Lead Independent Director 0.00%
Gregory Smith Former Executive Vice President of Enterprise Operations 0.00%
Matthew Walter Senior Vice President of Human Resources, IT and Global Communications & Corporate Marketing 0.00%
Sean Salmon Executive VP & President of Cardiovascular Portfolio 0.00%
Michael Marinaro President and President of Medical Surgical Portfolio, Americas & Global Commercial Ops 0.00%
Kendall Powell Independent Director 0.00%
Ivan Fong General Counsel 0.00%
Scott Donnelly Independent Director 0.00%
Elizabeth Nabel Independent Director 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-01 Michael Marinaro President and President of Medical Surgical Portfolio, Americas & Global Commercial Ops Other Acquisition +6,547 --
2026-11-01 Michael Marinaro President and President of Medical Surgical Portfolio, Americas & Global Commercial Ops Other Derivative Acquisition +16,367 --
2026-11-01 Michael Marinaro President and President of Medical Surgical Portfolio, Americas & Global Commercial Ops Other Derivative Acquisition +42,994 $99.29
2026-10-14 Kevin Lofton Independent Director Other Disposition -182 --
2026-10-14 Geoffrey Martha Chairperson & CEO Automatic Disposition -50,000 $95.00
2026-10-14 Geoffrey Martha Chairperson & CEO Intent to Sell (Form 144) -50,000 $95.00
2026-10-14 Michael Marinaro President and President of Medical Surgical Portfolio, Americas & Global Commercial Ops Automatic Disposition -10,420 $96.00
2026-10-14 Michael Marinaro Executive VP and President of Medical Surgical Portfolio & Americas Intent to Sell (Form 144) -10,420 $96.00
2026-09-15 Harry Kiil Executive VP & President of Cardiovascular Portfolio Open Market Disposition -1,483 $93.65
2026-09-14 Denise Blomquist VP, Global Controller & Chief Accounting Officer Other Disposition -600 --
2026-08-19 Michael Marinaro President and President of Medical Surgical Portfolio, Americas & Global Commercial Ops Sale to Issuer -1,084 $92.30
2026-08-02 Geoffrey Martha Chairperson & CEO Other Acquisition +41,533 --
2026-08-02 Geoffrey Martha Chairperson & CEO Other Derivative Acquisition +103,831 --
2026-08-02 Geoffrey Martha Chairperson & CEO Other Derivative Acquisition +568,152 $86.68
2026-08-02 Thierry Pieton Chief Financial Officer Other Acquisition +11,537 --
2026-08-02 Thierry Pieton Chief Financial Officer Other Derivative Acquisition +28,842 --
2026-08-02 Thierry Pieton Chief Financial Officer Other Derivative Acquisition +81,945 $86.68
2026-08-02 Harry Kiil Executive VP & President of Cardiovascular Portfolio Other Acquisition +9,230 --
2026-08-02 Harry Kiil Executive VP & President of Cardiovascular Portfolio Other Derivative Acquisition +23,074 --
2026-08-02 Harry Kiil Executive VP & President of Cardiovascular Portfolio Other Derivative Acquisition +65,556 $86.68

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:31 · For reference only, not investment advice and not tailored to your situation.

Medtronic discussion 0 comments

Add a comment